A new portable brain scanner for early detection of Alzheimer's disease
Prism-PET/EMMT: High resolution, cost effective, portable, and upright brain PET scanner for early diagnosis of Alzheimer's disease
This study is testing a new, easy-to-use brain scanner that helps find early signs of Alzheimer's disease, making it easier for people to get checked even if they don't have symptoms yet.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10947888 on NIH RePORTER |
What this research studies
This research focuses on developing a high-resolution, cost-effective, and portable brain PET scanner designed to improve the early diagnosis of Alzheimer's disease. The innovative Prism-PET scanner, combined with an electromagnetic motion tracker, aims to enhance imaging of critical brain regions affected by tau accumulation. By utilizing a specific PET radiotracer, the study seeks to identify early biomarkers of Alzheimer's in individuals who may not yet show symptoms. This approach aims to increase access to advanced brain imaging, particularly in community settings.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults over 21 years old who are at risk for or showing early signs of Alzheimer's disease.
Not a fit: Patients with advanced Alzheimer's disease or those who do not exhibit any symptoms of cognitive decline may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of Alzheimer's disease, allowing for timely interventions.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques for Alzheimer's diagnosis, but this specific approach with the Prism-PET scanner is novel.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Goldan, Amirhossein — Weill Medical Coll of Cornell Univ
- Study coordinator: Goldan, Amirhossein
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.